Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Examine the tax effects of rebalancing a portfolio and practical ways to minimize tax impact. This intro covers common scenarios and planning ideas.
21,738 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
Investing hinges on leadership as much as numbers. This guide dives into how Josh D'Amaro's new approach could influe...
As the Great Migration accelerates, Vanguard’s Value ETF is leading a rotation into cash-generative stocks, signaling...
Arthur Hayes liquidated his entire Zcash position after a publicly disclosed Orchard Pool vulnerability. The move und...
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...
Long-dated Treasury ETFs have struggled as long-end yields climb. This piece explains why holding long-duration funds...
As Nvidia powers AI breakthroughs and data centers expand, silver’s role in electronics could rise. This guide breaks...
Trump signals he will appoint a personal lawyer to run the Southern District of New York, a post with sweeping reach ...
CoStar Group blends a high performing CRE data backbone with a slower moving homes marketplace. This piece breaks dow...
The stock market poised crazy scenario is back in focus as Warsh signals could unlock a rapid shift in policy and mar...
A newCapital Economics note warns that the current rotation in U.S. equities could be a forerunner to a broader corre...